MedTrace Logo

Bone Mineral Density in Adult Survivors of Solid Pediatric Cancers

NCT00634816 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2013-05-30

No results posted yet for this study

Summary

Specific subgroups of children who survive treatment for childhood malignancies have been shown to develop relative osteopenia following chemotherapy and are felt to be at risk for developing osteoporosis later in life due to their inability to reach peak bone mass during childhood.

Conditions

  • Regional Osteoporosis as a Result of Chemotherapy

Interventions

RADIATION

DXA Scan

The patients will undergo total body, spine, proximal femoral, and forearm DEXA testing in a standardized fashion. Patients who have undergone limb surgery or irradiation to an extremity for local disease control will also undergo selected site DEXA or pQCT scanning, depending upon the site, of the affected extremity and the identical site on the contra-lateral extremity.

Sponsors & Collaborators

  • State University of New York - Upstate Medical University

    lead OTHER

Principal Investigators

  • Timothy A Damron, MD · State University of New York - Upstate Medical University

Eligibility

Min Age
16 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-04-30
Primary Completion
2006-04-30
Completion
2006-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00634816 on ClinicalTrials.gov